CRIMEAN-CONGO HEMORRHAGIC FEVER IN IRAQ (2018-2022) AND AN EDUCATIONAL REVIEW
Keywords:
Abstract
Background: The first patient with Crimean-Congo hemorrhagic fever was reported in Iraq for the first time on 3rd of September, 1979, and recurrent outbreaks were recorded thereafter with none more patients observed during the next two years. Little is known about the epidemiological state of the disease in Iraq during the previous years.
Patients and methods: An overview of the cases of Crimean-Congo hemorrhagic fever registered by the Iraqi Ministry of Health from January, 2018 to May, 2022 is provided. An educational review is presented in the "Discussion".
Results: During the year 2018, there were ten cases (including 3 from Diwaniyia province) confirmed by Reverse Transcriptase Polymerase Chain Reaction registered by the Iraqi Ministry of Health, and death occurred in eight of the cases. During the year 2021, the Iraqi Ministry of Health reported the registration of fifteen laboratory confirmed cases of Crimean-Congo hemorrhagic fever during the period from April to November 2021, and 5 deaths occurred. On the 27th of April 2022, the Iraqi Ministry of Health registered 17 cases of laboratory confirmed hemorrhagic fever occurred during the year 2022, and many cases were from ThiQar, and five deaths occurred.
Conclusion: 42 cases of laboratory confirmed cases of Crimean-Congo hemorrhagic fever occurred in Iraq during the period from January, 2018 to May, 2022. The disease is still endemic in Iraq and was associated with a high mortality as 18 of the 42 confirmed cases died. Therefore, we are recommending using the available research evidence suggesting the early use of ribavirin in the treatment of patients, and also using ribavirin post-exposure prophylaxis and early ribavirin treatment for workers at medium-to-high risk.
Similar Articles
-
The Great Silk Road Monuments Of Northwest Bactria Kushan Period
The American Journal of Social Science and Education Innovations: No. 12 (2021) / Khumoyun Nazarov,
References
Al-Tikriti SK, Al-Ani F, Jurji FJ, et al. Congo/Crimean haemorrhagic fever in Iraq. Bull World Health Organ 1981; 59(1):85-90. PMID: 6790183.
Zeitlenok NA, Vanag KA, Pille ER. Zabolevanie tipa krymskoi gemorragicheskoi likhoradki v Astrakhanskoi oblasti [Crimean hemorrhagic fever type illness observed in Astrakhan region]. Vopr Virusol. 1957 Mar-Apr; 2(2):92-8. PMID: 13443243 [Article in Russian].
Chumakov MP. Studies of virus haemorrhagic fevers. J Hyg Epidemiol Microbiol Immunol 1963;7:125-35. PMID: 14040683.
Woodall JP, Williams MC, Simpson DI. Congo virus: a hitherto undescribed virus occurring in Africa. II. Identification studies. East Afr Med J. 1967 Feb; 44(2):93-8. PMID: 6068614.
Simpson DI, Knight EM, Courtois G, Williams MC, Weinbren MP, Kibukamusoke JW. Congo virus: a hitherto undescribed virus occurring in Africa. I. Human isolations: clinical notes. East Afr Med J 1967 Feb; 44(2):86-92. PMID: 6040759.
Chumakov MP, Butenko AM, Shalunova NV, Mart'ianova LI, Smirnova SE, Bashkirtsev IuN, Zavodova TI, Rubin SG, Tkachenko EA, Karmysheva VIa, Reĭngol'd VN, Popov GV, Savinov AP. Novye dannye o viruse-vozbuditele krymskoĭ gemorragicheskoĭ likhoradki [New data on the viral agent of Crimean hemorrhagic fever]. Vopr Virusol 1968 May-Jun; 13(3):377. PMID: 4235803 [Article in Russian].
Perelatov VD, Chumakova IV. K ekologii lkeshcha Hyalomma plumbeum v donetskom ochage drymskoĭ gemorragicheskoĭ likhoradki [On the ecology of Hyalomma plumbeum ticks in the Donetsk focus of Crimean hemorrhagic fever]. Med Parazitol (Mosk) 1967 May-Jun; 36(3):356-8. Russian. PMID: 5609989.
Casals J. Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus. Proc Soc Exp Biol Med 1969 May; 131(1):233-6. Doi: 10.3181/ 00379 727-131-33847. PMID: 5770109.
Ergönül Ö. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res 2008 Apr; 78(1):125-31. Doi: 10.1016/j.antiviral.2007.11.002. PMID: 18096251.
Tasdelen Fisgin N, Ergonul O, Doganci L, Tulek N. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur J Clin Microbiol Infect Dis 2009 Aug; 28(8):929-33. Doi: 10.1007/s10096-009-0728-2. PMID: 19301047.
Ergönül Ö, Keske Ş, Çeldir MG, Kara İA, Pshenichnaya N, Abuova G, Blumberg L, Gönen M. Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers. Emerg Infect Dis 2018 Sep; 24(9):1642-1648. Doi: 10.3201/eid2409.171709. PMID: 30124196.
